Third Rock Ventures Toggle navigation Philosophy Our Investment Strategy Discover. Launch. Build. Our Mission Core Values People Portfolio Media Center Careers Overview Opportunities Beyond Great Contact LinkedIn Close Third Rock launches Relay Therapeutics with $57M to build the worlds first dedicated drug discovery platform centered on protein motion Read More Jounce and celgene to collaborate on next-generation immuno-oncology therapies Read More Third Rock Launches Fulcrum Therapeutics to Transform Gene Regulation in Disease Read More Decibel Therapeutics Appoints Steven H. Holtzman as President and Chief Executive Officer Read More Merck to Acquire Afferent for up to $1.25 billion Read More Partner Profile: Kevin Gillis Read More Congratulations to Our 2016 NEVY Award Winners Editas Medicine and Decibel Therapeutics Read More Agios and Celgene Establish New Collaboration in Metabolic Immuno-Oncology Read More Blueprint Medicines Announces Worldwide Collaboration to Accelerate and Expand its Development of Novel Medicines in the Field of Cancer Immunotherapy Read More CytomX and AbbVie Announce Strategic Collaboration for Probody Drug Conjugates Read More Nature Biotechnology highlights Neon Therapeutics in it's list of academic spinouts of 2015 Read More Congratulations to Voyager Therapeutics on being named one of The Boston Business Journal's 2016 Best Places to Work Read More Pliant Therapeutics launches with $45 million to develop breakthrough treatments for fibrotic diseases Read More Take a look at what weve been up to for the past 8+ years Watch the Video Sign up for weekly portfolio company news alerts here Read More Andrew Stricos, who has Huntingtons disease, and his wife tell their story at a luncheon hosted by Third Rock Watch the Video Transforming Healthcare 40 Portfolio Companies With More Than $1.3 Billion Under Management 45 Clinical Studies Underway Within Our Portfolio 60 Diseases Being Targeted By Our Companies 10 of thousands Patients Impacted By Portfolio Company Products and Clinical Trials × Andrew Stricos, who has Huntingtons disease, and his wife tell their story at a luncheon hosted by Third Rock × Partner Charles Homcy Shares the Story of Founding MyoKardia Close Boston 29 Newbury Street 3rd floor Boston, MA 02116 P (617) 585-2000 F (617) 859-2891 Email San Francisco 455 Mission Bay Blvd South Suite 575 San Francisco, CA 94158 P (415) 766-3600 F (415) 766-3699 Site map Philosophy People Portfolio Media Center Careers Contact Social Submit interesting, disruptive ideas here Copyright © 2016 Third Rock Ventures, LLC. All Rights Reserved. Terms of Use Privacy Policy Terms of Use Privacy Policy